[go: up one dir, main page]

WO2004046103A3 - Arylpyridine compounds - Google Patents

Arylpyridine compounds Download PDF

Info

Publication number
WO2004046103A3
WO2004046103A3 PCT/US2003/036732 US0336732W WO2004046103A3 WO 2004046103 A3 WO2004046103 A3 WO 2004046103A3 US 0336732 W US0336732 W US 0336732W WO 2004046103 A3 WO2004046103 A3 WO 2004046103A3
Authority
WO
WIPO (PCT)
Prior art keywords
arylpyridine compounds
arylpyridine
compounds
methods
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/036732
Other languages
French (fr)
Other versions
WO2004046103A2 (en
Inventor
Nathaniel S Finney
Albert G Fang
Jesse V Mello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to AU2003291021A priority Critical patent/AU2003291021A1/en
Publication of WO2004046103A2 publication Critical patent/WO2004046103A2/en
Publication of WO2004046103A3 publication Critical patent/WO2004046103A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to arylpyridine compounds and methods of using them.
PCT/US2003/036732 2002-11-18 2003-11-18 Arylpyridine compounds Ceased WO2004046103A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003291021A AU2003291021A1 (en) 2002-11-18 2003-11-18 Arylpyridine compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42760602P 2002-11-18 2002-11-18
US60/427,606 2002-11-18

Publications (2)

Publication Number Publication Date
WO2004046103A2 WO2004046103A2 (en) 2004-06-03
WO2004046103A3 true WO2004046103A3 (en) 2005-02-24

Family

ID=32326569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/036732 Ceased WO2004046103A2 (en) 2002-11-18 2003-11-18 Arylpyridine compounds

Country Status (2)

Country Link
AU (1) AU2003291021A1 (en)
WO (1) WO2004046103A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8367680B2 (en) 2008-03-28 2013-02-05 Wisconsin Alumni Research Foundation Antibacterial small molecules and methods for their synthesis
CN105111139B (en) * 2015-08-17 2018-01-30 上海博志研新药物技术有限公司 A kind of synthetic method of medicine intermediate diaryl substituted pyridine derivative
IL269036B2 (en) * 2017-03-08 2023-03-01 Nimbus Lakshmi Inc Tyk2 inhibitors, uses, and methods for production thereof
CN115322146B (en) * 2022-07-06 2024-04-19 安徽峆一药业股份有限公司 Preparation method of 4-amino-2, 6-dichloropyridine

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BROOKS J.: "Synthesis and characterization of phosphorescent cyclometalated platimun complexes", INORGANIC CHEMISTRY, vol. 41, pages 3055 - 3066, XP002982403 *
CHEM. BER., pages 929 - 932 *
DATABASE CA [online] 1992, TIMARI ET AL.: "Synthesis and methylation of two differently fused benzologs of pyrido[1,2-b]pyridazinium-4-olate", XP002982429, Database accession no. 117:191790 *
DATABASE CA [online] 2001, "Convenient synthesis and transformation of 2,6-dichloro-4-iodopyridine", XP002982404, Database accession no. 136:134656 *
ORGANIC LETTERS, pages 4263 - 4265 *
PALANKI M.S.: "Novel inhibitors of AP-1 and NF-kB mediated gene expression: structure-activity relationship studies of ethyl 4-[(methyl-2,5-dioxo(3-pyrrolinyl)amino]-2-(trifluoromethyl)pyridimidine-5-carboxylate", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 10, 2000, pages 1545 - 1648, XP004213214 *
TICE C.M.: "Regiocontrolled synthesis of 3-substituted-6-trifluoromethyl-4(3H)-pyrimidinones", TETRAHEDRON, vol. 57, 2001, pages 2689 - 2700, XP004232228 *

Also Published As

Publication number Publication date
AU2003291021A8 (en) 2004-06-15
AU2003291021A1 (en) 2004-06-15
WO2004046103A2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
WO2003077867A3 (en) Naltrexone hydrochloride compositions
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
WO2004052522A3 (en) Water-soluble products and methods of making and using the same
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
PL359056A1 (en) Compound emulsion, method of manufacture of the compound emulsion and application of the compound emulsion
AU2003299612A1 (en) Compounds, compositions and methods
WO2004091572A3 (en) Cochleate compositions directed against expression of proteins
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003277596A1 (en) Method of deuterization
WO2003037262A3 (en) Novel anit-infectives
WO2004043379A3 (en) Chemical compounds
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003269126A1 (en) Method of combining materials
WO2004052312A3 (en) Anti-infectives
AU2003290507A1 (en) Compounds, compositions and methods
WO2002076396A3 (en) Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2003206367A1 (en) Technical field of the invention
AUPS096002A0 (en) Method of construction
WO2004047751A3 (en) Calcilytic compounds
WO2004026892A3 (en) Fragmentation of dna
WO2004046103A3 (en) Arylpyridine compounds
AU2003300031A1 (en) Compounds, compositions, and methods
AU2003269192A1 (en) Method for improving or enhancing the appearance of teeth

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP